Published in Int Arch Allergy Appl Immunol on January 01, 1971
Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacteriol Rev (1977) 13.47
Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev (1991) 7.11
Enterobacterial common antigen. Bacteriol Rev (1976) 2.41
Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. J Clin Invest (1978) 1.18
Common epitopes between mycobacterial and certain host tissue antigens. Clin Exp Immunol (1985) 0.89
Hypertension, asymmetric renal parenchymal defect, sterile urine, and high E. coli antibody titre. Br Med J (1973) 0.75
Interstitial nephritis in rats produced by E. coli in adjuvant: immunological findings. Clin Exp Immunol (1977) 0.75
Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med (1974) 7.89
Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet (1976) 7.15
Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid. Infect Immun (1973) 6.58
Enzyme-linked immunosorbent assays for cholera serology. Infect Immun (1973) 6.10
Adhesion of Escherichia coli to human uroepithelial cells in vitro. Infect Immun (1977) 5.28
Actions of cholera toxin and the prevention and treatment of cholera. Nature (1981) 4.78
Resistance to erythromycin in group A streptococci. N Engl J Med (1992) 4.42
Tissue receptor for cholera exotoxin: postulated structure from studies with GM1 ganglioside and related glycolipids. Infect Immun (1973) 4.08
Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology (1986) 3.28
Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J Infect Dis (1984) 3.07
Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J Clin Invest (1991) 2.97
Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid. Infect Immun (1976) 2.92
Frequency of E. coli K antigens in urinary-tract infections in children. Lancet (1977) 2.89
Synthesis of a precursor to the B subunit of heat-labile enterotoxin in Escherichia coli. J Bacteriol (1981) 2.84
Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J Infect Dis (1985) 2.78
Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J Clin Microbiol (1986) 2.77
Antibody-forming cells in human colostrum after oral immunisation. Nature (1975) 2.76
Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun (1989) 2.74
Comparison of Escherichia coli from bacteriuric patients with those from feces of healthy schoolchildren. J Infect Dis (1977) 2.72
Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis (1978) 2.72
Monoclonal antibodies against Escherichia coli heat-stable toxin (STa) and their use in a diagnostic ST ganglioside GM1-enzyme-linked immunosorbent assay. J Clin Microbiol (1986) 2.65
Adhesion to normal human uroepithelial cells of Escherichia coli from children with various forms of urinary tract infection. J Pediatr (1978) 2.60
The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur J Immunol (1992) 2.52
Breast milk and defence against infection in the newborn. Arch Dis Child (1972) 2.51
Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am J Epidemiol (1985) 2.49
Interaction of cholera toxin and toxin derivatives with lymphocytes. I. Binding properties and interference with lectin-induced cellular stimulation. J Exp Med (1974) 2.42
Development of improved cholera vaccine based on subunit toxoid. Nature (1977) 2.42
The bactericidal effect of normal human serum on E. coli strains from normals and from patients with urinary tract infections. Infection (1973) 2.39
Experimental studies on cholera immunization. II. Evidence for protective antitoxic immunity mediated by serum antibodies as well as local antibodies. Infect Immun (1972) 2.37
Adhesion of Streptococcus pneumoniae to human pharyngeal epithelial cells in vitro: differences in adhesive capacity among strains isolated from subjects with otitis media, septicemia, or meningitis or from healthy carriers. Infect Immun (1981) 2.33
IgG subclasses in selective IgA deficiency: importance of IgG2-IgA deficiency. N Engl J Med (1981) 2.18
Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. Proc Natl Acad Sci U S A (1975) 2.18
Mechanisms of disease and immunity in cholera: a review. J Infect Dis (1977) 2.17
Invasive group A streptococcal infections. N Engl J Med (1996) 2.16
Adhesion of Escherichia coli in urinary tract infection. Ciba Found Symp (1981) 2.15
Intestinal antibody responses after immunisation with cholera B subunit. Lancet (1982) 2.13
Correlation between intestinal synthesis of specific immunoglobulin A and protection against experimental cholera in mice. Infect Immun (1978) 2.12
Mechanism of toxin secretion by Vibrio cholerae investigated in strains harboring plasmids that encode heat-labile enterotoxins of Escherichia coli. Proc Natl Acad Sci U S A (1984) 2.10
Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J Immunol (1991) 2.08
Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. J Infect Dis (1983) 2.08
Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin. Infect Immun (1982) 2.08
Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun (1997) 2.05
Cross-reactivity between heat labile enterotoxins of Vibrio cholerae and Escherichia coli in neutralization tests in rabbit ileum and skin. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 2.04
Public health. The cholera crisis in Africa. Science (2009) 2.02
Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J Clin Invest (1997) 1.98
Identification of a mannose-binding pilus on Vibrio cholerae El Tor. Microb Pathog (1991) 1.94
Enterotoxin-producing bacteria and parasites in stools of Ethiopian children with diarrhoeal disease. Arch Dis Child (1976) 1.94
Fixation and inactivation of cholera toxin by GM1 ganglioside. Scand J Infect Dis (1973) 1.90
Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin. Infect Immun (1987) 1.89
Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside. Eur J Biochem (1981) 1.89
Cloning and sequencing of Vibrio cholerae mannose-sensitive haemagglutinin pilin gene: localization of mshA within a cluster of type 4 pilin genes. Mol Microbiol (1994) 1.88
Protective antitoxic cholera immunity in mice: influence of route and number of immunizations and mode of action of protective antibodies. Acta Pathol Microbiol Scand C (1978) 1.86
Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin. Infect Immun (1983) 1.84
Conformation of protein secreted across bacterial outer membranes: a study of enterotoxin translocation from Vibrio cholerae. Proc Natl Acad Sci U S A (1987) 1.84
Boosting of secretory IgA antibody responses in man by parenteral cholera vaccination. Scand J Immunol (1977) 1.83
Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans. Infect Immun (1991) 1.82
Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization. Infect Immun (1975) 1.82
Subunit structure of cholera toxin. J Gen Microbiol (1973) 1.78
Primary hypogammaglobulinaemia: impaired lung function and body growth with delayed diagnosis and inadequate treatment. Eur J Respir Dis (1984) 1.77
Asymptomatic bacteriuria in schoolgirls. II. Differences in escherichia coli causing asymptomatic bacteriuria. Acta Paediatr Scand (1975) 1.76
Evaluation of methods for epidemiologic typing of group A streptococci. J Infect Dis (1994) 1.75
Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc Natl Acad Sci U S A (1989) 1.74
Protective factors in milk and the development of the immune system. Pediatrics (1985) 1.73
Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea. Vaccine (1989) 1.73
Relative significance of mannose-sensitive hemagglutinin and toxin-coregulated pili in colonization of infant mice by Vibrio cholerae El Tor. Infect Immun (1996) 1.70
Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis. N Engl J Med (1983) 1.70
Evaluation of a ganglioside immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1979) 1.70
Role of PCF8775 antigen and its coli surface subcomponents for colonization, disease, and protective immunogenicity of enterotoxigenic Escherichia coli in rabbits. Infect Immun (1988) 1.69
Coordinated assembly of multisubunit proteins: oligomerization of bacterial enterotoxins in vivo and in vitro. Proc Natl Acad Sci U S A (1988) 1.68
Transient entry of enterotoxin subunits into the periplasm occurs during their secretion from Vibrio cholerae. J Bacteriol (1987) 1.68
Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology (1999) 1.68
Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J Gen Virol (2001) 1.67
Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. Int Arch Allergy Appl Immunol (1983) 1.67
Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect Immun (1998) 1.67
Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci U S A (1994) 1.66
Protection against cholera in breast-fed children by antibodies in breast milk. N Engl J Med (1983) 1.64
Quantitation of vibriocidal antibodies using agar plague techniques. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 1.63
Experimental studies on cholera immunization. 1. The response of neutralizing and vibriocidal antibodies in rabbits after immunization with culture filtrate material from V. cholerae. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 1.63
Cholera toxin structure, gene regulation and pathophysiological and immunological aspects. Cell Mol Life Sci (2008) 1.62
Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes. Bull World Health Organ (1984) 1.62
Monoclonal antibodies to Escherichia coli heat-labile enterotoxins: neutralising activity and differentiation of human and porcine LTs and cholera toxin. Med Biol (1986) 1.61
Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. Proc Natl Acad Sci U S A (1977) 1.61
Immunoprecipitating factors of vaccinia virus. Virology (1965) 1.60
A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29. Appl Environ Microbiol (1996) 1.60
Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin Exp Immunol (2003) 1.60
Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med (1988) 1.59
Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine. Vaccine (1993) 1.54
Immunodiffusion studies on Escherichia coli. 1. Identification of O, K and H antigens in an O6 strain. Acta Pathol Microbiol Scand (1969) 1.54
Induction of compartmentalized B-cell responses in human tonsils. Infect Immun (1995) 1.54
Intestinal mucosal memory and presence of memory cells in lamina propria and Peyer's patches in mice 2 years after oral immunization with cholera toxin. Scand J Immunol (1986) 1.52
Protective capacity of antibodies against E. coli O antigen with special reference to the avidity. Int Arch Allergy Appl Immunol (1974) 1.49
Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine (1992) 1.49
Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections. J Infect Dis (1977) 1.48
Vibrio cholerae expresses cell surface antigens during intestinal infection which are not expressed during in vitro culture. Infect Immun (1989) 1.48
Bovine immunodeficiency virus in stud bull semen. Am J Vet Res (1995) 1.47